Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CNTA
CNTA News & Events
-
Add to Watchlist
Trade CNTA
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
CNTA News
Centessa Pharmaceuticals Presents New OX2R Agonist Data, Enhancing Mood in Depression Models
Jan 14 2026
Globenewswire
Centessa Pharmaceuticals (CNTA) Shares Hit $22.44 with RSI at 28.4, Indicating Oversold Condition
Jan 05 2026
NASDAQ.COM
U.S. Stocks Rise, NVIDIA Target Price Set at $250
Jan 05 2026
Benzinga
Centessa Pharmaceuticals Appoints Accardi as CEO, Focusing on Orexin Drug Development
Dec 11 2025
Globenewswire
Centessa Pharmaceuticals Appoints Accardi as CEO, Focusing on Orexin Drug Development
Dec 11 2025
Newsfilter
Centessa Pharmaceuticals CEO Saurabh Saha Resigns; Mario Accardi Appointed as Successor
Dec 11 2025
NASDAQ.COM
5AM Venture Sells Its Viking Stake—Wise Decision or Lost Chance?
Nov 18 2025
NASDAQ.COM
5AM Venture Exits MoonLake Following a Challenging Year: Key Highlights to Note
Nov 18 2025
NASDAQ.COM
Show More News
CNTA Events
12/11 10:10
Centessa Shares Down 8.4% to $27.08
Centessa is down -8.4%, or -$2.49 to $27.08.
Show More Events
CNTA Monitor News
No data
CNTA Earnings Analysis
No Data
People Also Watch
